ImpediMed Limited (ASX:IPD)
0.0190
-0.0020 (-9.52%)
Feb 5, 2026, 4:10 PM AEST
ImpediMed Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 22.18 | 24.63 | 45.71 | 40.73 | 19.68 |
Cash & Short-Term Investments | 22.18 | 24.63 | 45.71 | 40.73 | 19.68 |
Cash Growth | -9.94% | -46.11% | 12.23% | 106.95% | 0.09% |
Accounts Receivable | 2.42 | 2.19 | 2.63 | 2.75 | 2.78 |
Other Receivables | 1.23 | 1.01 | 1.76 | 1.63 | 1.83 |
Receivables | 3.65 | 3.2 | 4.38 | 4.38 | 4.6 |
Inventory | 0.86 | 0.76 | 0.81 | 0.93 | 0.37 |
Prepaid Expenses | 0.81 | 0.86 | 1.03 | 0.62 | 1 |
Total Current Assets | 27.51 | 29.46 | 51.94 | 46.66 | 25.65 |
Property, Plant & Equipment | 0.88 | 1.45 | 1.95 | 0.42 | 1.03 |
Long-Term Investments | - | - | - | 0.08 | 0.07 |
Goodwill | 2.78 | 2.72 | 2.73 | 2.63 | 2.42 |
Other Intangible Assets | 10.19 | 13.31 | 12.04 | 8.74 | 5.04 |
Long-Term Accounts Receivable | 0.23 | - | - | 0.18 | - |
Other Long-Term Assets | 0.07 | 0.05 | 0.08 | - | - |
Total Assets | 41.66 | 46.99 | 68.74 | 58.7 | 34.21 |
Accounts Payable | 1.06 | 1.1 | 1.36 | 2.64 | 1.3 |
Accrued Expenses | 2 | 1.67 | 3.1 | 3.45 | 5.56 |
Current Portion of Leases | 0.27 | 0.33 | 0.3 | 0.17 | 0.32 |
Current Unearned Revenue | 2.33 | 1.49 | 1.03 | 0.93 | 0.88 |
Other Current Liabilities | 0.02 | 0.07 | 0.06 | 0.06 | 0.08 |
Total Current Liabilities | 5.66 | 4.66 | 5.85 | 7.24 | 8.13 |
Long-Term Debt | 13.79 | - | - | - | - |
Long-Term Leases | 0.43 | 0.81 | 1.15 | - | 0.16 |
Long-Term Unearned Revenue | 1.17 | 0.7 | 0.42 | 0.36 | 0.22 |
Pension & Post-Retirement Benefits | 0.04 | 0.05 | 0.42 | - | - |
Other Long-Term Liabilities | 0.07 | 0.03 | 0.03 | 0.05 | 0.18 |
Total Liabilities | 21.16 | 6.24 | 7.86 | 7.66 | 8.69 |
Common Stock | 336.15 | 336.15 | 336.09 | 307.56 | 267.27 |
Retained Earnings | -354.19 | -330.95 | -311.16 | -290.64 | -270.77 |
Comprehensive Income & Other | 38.54 | 35.55 | 35.95 | 34.13 | 29.01 |
Shareholders' Equity | 20.5 | 40.74 | 60.88 | 51.04 | 25.51 |
Total Liabilities & Equity | 41.66 | 46.99 | 68.74 | 58.7 | 34.21 |
Total Debt | 14.49 | 1.14 | 1.45 | 0.17 | 0.47 |
Net Cash (Debt) | 7.69 | 23.49 | 44.26 | 40.56 | 19.21 |
Net Cash Growth | -67.25% | -46.93% | 9.13% | 111.17% | 2.21% |
Net Cash Per Share | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 |
Filing Date Shares Outstanding | 2,030 | 2,023 | 2,019 | 1,780 | 1,494 |
Total Common Shares Outstanding | 2,027 | 2,023 | 2,018 | 1,778 | 1,492 |
Working Capital | 21.85 | 24.8 | 46.09 | 39.42 | 17.52 |
Book Value Per Share | 0.01 | 0.02 | 0.03 | 0.03 | 0.02 |
Tangible Book Value | 7.53 | 24.72 | 46.11 | 39.68 | 18.06 |
Tangible Book Value Per Share | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 |
Machinery | 2.87 | 2.84 | 2.79 | 2.72 | 2.09 |
Leasehold Improvements | 0.19 | 0.19 | 0.19 | 0.19 | 0.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.